Ibogaine Club Research Group Submits Detailed Public Comment to FDA on ... - Mirror-Democrat

The comment addresses the agency's Request for Information on design and safety considerations for clinical trials involving ibogaine drug products.

Share this story

Surfaced by this Google Alert